Observational studyJournal of neurology2024

Risk of hepatitis B virus reactivation in people with multiple sclerosis treated with ocrelizumab: an observational study from Turkey.

Muammer Çelik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.